• 31 Days of CF: Tiffany’s Story
  • Kalydeco Shows Long-term Efficacy in CF Patients in Real-world Setting
  • 31 Days of CF: Kate’s Story
  • ‘Rare Barometer’ Program Helps Eurordis Shape EU Rare Disease Policy
  • How to Overcome the Scourge of Confirmation Bias
  • Eluforsen Found to be Safe for Adults with Cystic Fibrosis Caused by F508del Mutation, Study Reports
  • 31 Days of CF: Steven’s Story
  • 31 Days of CF: Jenny’s Story
  • Bronchitol, Inhalation Powder for CF Patients, to Enter Swiss Market
  • 31 Days of CF: Catherine’s Story
  • Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical Data Show